• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Prenuvo Research Reveals Link Between Type 2 Diabetes and Brain Aging

by Jasmine Pennic 12/05/2024 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

What You Should Know: 

– Prenuvo, a provider of proactive whole-body MRI scans, has presented groundbreaking research at the Radiological Society of North America (RSNA) 2024 Annual Meeting, revealing a significant link between Type 2 diabetes and brain volume loss. 

– The new study highlights the potential of whole-body MRI screening to uncover the hidden impacts of chronic conditions on brain health.

Diabetes and Brain Aging: New Insights

The study, involving over 650 participants, is one of the largest MRI-based analyses to date examining the relationship between Type 2 diabetes and brain aging. Using Prenuvo’s whole-body MRI scans and AI-powered analysis, researchers found that individuals with Type 2 diabetes exhibit reduced brain volume, particularly in the white matter of the occipital lobe, the region responsible for processing visual information and spatial reasoning.

Research Key Findings

  • White matter most affected: Significant reductions in white matter volume were observed in diabetic patients, indicating an increased risk for brain aging.
  • Association with neurological conditions: The observed brain changes suggest a potential link between diabetes and cognitive decline, including memory impairment.
  • Importance of early intervention: The findings underscore the need for early detection and management of diabetes to preserve both metabolic and cognitive health.

“This is the first time that we’ve been able to pinpoint the areas of the brain most impacted by diabetes, so physicians and patients can take specific actions to enhance those brain areas by doing cognitive exercises,” said Sam Hashemi, VP of Artificial Intelligence & Research at Prenuvo. “These results also provide evidence that we should not limit screening for this chronic disease to blood and organ-specific tests, and instead perform a more comprehensive screening.”

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Paradigm Shift in Diabetes Care with Studio Clinics: Q&A with Reach7 Founder Chun Yong

Most-Read

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

2019 MedTech Breakthrough Award Category Winners Announced

MedTech Breakthrough Announces 2025 MedTech Breakthrough Award Winners

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |